Open Access

SGLT2 inhibitors in HFpEF - Light at the end of the tunnel.

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Organised by Radcliffe Medical Education - Supported by an unrestricted educational grant from AstraZeneca

Congress Session

About the speaker

Professor Scott Solomon

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
43 presentations
13 followers

5 more presentations in this session

SGLT2 inhibitors across the spectrum of heart failure.

Speaker: Professor J. McMurray (Glasgow, GB)

Thumbnail

Practical considerations for treating HF with mildly reduced and preserved EF.

Speaker: Professor C. Lam (Singapore, SG)

Thumbnail

Implementing best practices across the spectrum of heart failure.

Speaker: Doctor M. Vaduganathan (Boston, Massachusetts, US)

Thumbnail

Access the full session

SGLT-2 inhibitors - Another piece of the puzzle in heart failure

Speakers: Professor S. Solomon, Professor J. McMurray, Professor C. Lam, Doctor M. Vaduganathan
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk